Prescription Drugs 2 Go

CONCLUSIONS: More women experienced pain relief, and fewer had additional pain relief, with paracetamol compared with placebo, although potential adverse effects were not assessed and generally the quality of studies was unclear.
PMID: 20238369 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)

The U.S. Food and Drug Administration (FDA) recognizes the five-fold increase in unintentional drug overdose deaths noted by the Centers for Disease Control and Prevention between 1990 and 2006 as a serious public health concern. Much of this increase follows from increases in the deaths from the use of opioid drugs, which in 2006 accounted for more overdose deaths than heroin and cocaine combined. The agency is also concerned about misuse of benzodiazepines (e.g., Valium and Xanax), which accounted for 272,000 emergency department visits in 2008 (compared to 306,000 for …

Astrup A, Rössner S, Van Gaal L, et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374: 1606–16—In this Article (Nov 7), the proportion of patients with metabolic syndrome in table 1 (p 1608) should have been: 51% for placebo, 42% for liraglutide 1·2 mg, 36% for liraglutide 1·8 mg, 34% for liraglutide 2·4 mg, 41% for liraglutide 3·0 mg, and 38% for orlistat. The second and third sentences of the seventh paragraph in the Results section (p 1611) should have read: …

Attention deficit disorder is not just a childhood disorder. Adults can be diagnosed with attention deficit disorder (ADHD) as well. Sometimes this is a result of the person’s childhood ADHD progressing into adulthood (up to 70 percent of children will continue to struggle with ADHD as adults). Other times, an adult can either simply never been diagnosed as a child, or develop the disorder later on in life.
Adult attention deficit disorder looks a lot like childhood attention deficit disorder. That shouldn’t come as a surprise, since the symptoms are largely …

WASHINGTON (MedPage Today) — The FDA has approved a new indication for botulinum toxin type A (Botox) as a flexor muscle spasm treatment for the elbow, wrist, and fingers in adult patients. (Source: MedPage Today Product Alert)

The FDA has approved a new indication for onabotulinumtoxin A injection for spasticity in the flexor muscles of the elbow, wrist, and fingers for adults. Medscape Medical News (Source: Medscape Business of Medicine Headlines)

The FDA has approved a new indication for onabotulinumtoxin A injection for spasticity in the flexor muscles of the elbow, wrist, and fingers for adults. Medscape Medical News (Source: Medscape Business of Medicine Headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

The FDA has approved a new indication for onabotulinumtoxin A injection for spasticity in the flexor muscles of the elbow, wrist, and fingers for adults. Medscape Medical News (Source: Medscape Today Headlines)

Medicis has started a new marketing campaign that pits its wrinkle-smoother, Dysport, directly against Botox. It makes bioethicists squirm. (Source: NYT > Health)

Medicis has started a new marketing campaign that pits its wrinkle-smoother, Dysport, directly against Botox. It makes bioethicists squirm. (Source: NYT)